Article
Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib
15 Mar 2012
Abstract excerpt
As NK cell immunotherapy is still poorly successful, combinations with drugs enhancing NK cell activity are of major interest. NK large granular lymphocyte expansions associated with improved survival have been described under monotherapy with the Bcr-Abl/Src inhibitor dasatinib, which inhibits NK cell functions in vitro. As Src kinases play a major role in inhibitory and activating signaling pathways of NK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
